The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). 

Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. 

The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. 

It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. 

Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book presents the currently available clinical, epidemiological, and experimental data on short bowel syndrome (SBS), with special emphasis on the medical, surgical, and nutritional care of patients affected by SBS, based on the most up-to-date, evidence-based data available.The prevalence of SBS has been rising along with significant advances in medicine and the overcoming of barriers such as more aggressive cancer resections and the increase in life expectancy, which has led to a higher prevalence of mesenteric ischemia and thrombosis. More recently, the SARS-CoV-2 infection has caused an increase in the incidence of thrombosis. The rising prevalence of SBS has prompted researchers and healthcare professionals to explore innovative treatments such as intestinal transplantation and the development of specialized diets and medications to improve patients' quality of life.The volume emphasizes the use of growth factors, which are likely to become increasingly important for promoting the structural adaptability of the intestine. It also highlights the need for ongoing research in the field of SBS to further understand the underlying mechanisms and develop new treatment options. Additionally, it highlights the importance of patient education and empowerment in managing their condition and making informed decisions about their care.The importance of a skilled interdisciplinary team in providing care for these individuals is also outlined. This book will serve as a quick reference on the medical, surgical, and nutritional care of complex patients with SBS, for nutritionists, dietitians, general practitioners, gastroenterologists, surgeons, nurses, and pharmacists alike.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). 

Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. 

The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. 

It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. 

Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD). Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes. The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume. It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options. Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.

The book presents the currently available clinical, epidemiological, and experimental data on short bowel syndrome (SBS), with special emphasis on the medical, surgical, and nutritional care of patients affected by SBS, based on the most up-to-date, evidence-based data available.The prevalence of SBS has been rising along with significant advances in medicine and the overcoming of barriers such as more aggressive cancer resections and the increase in life expectancy, which has led to a higher prevalence of mesenteric ischemia and thrombosis. More recently, the SARS-CoV-2 infection has caused an increase in the incidence of thrombosis. The rising prevalence of SBS has prompted researchers and healthcare professionals to explore innovative treatments such as intestinal transplantation and the development of specialized diets and medications to improve patients' quality of life.The volume emphasizes the use of growth factors, which are likely to become increasingly important for promoting the structural adaptability of the intestine. It also highlights the need for ongoing research in the field of SBS to further understand the underlying mechanisms and develop new treatment options. Additionally, it highlights the importance of patient education and empowerment in managing their condition and making informed decisions about their care.The importance of a skilled interdisciplinary team in providing care for these individuals is also outlined. This book will serve as a quick reference on the medical, surgical, and nutritional care of complex patients with SBS, for nutritionists, dietitians, general practitioners, gastroenterologists, surgeons, nurses, and pharmacists alike.